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Multimodality therapy has greatly improved the prognosis of
patients with localized osteosarcoma, over 50% of patients
remaining free of disease for up to 5 years after treatment [1e4].
Most relapses, especially in the form of early pulmonary
metastasis, usually occur within 2e3 years after treatment.
Relapse after 5 years is uncommon and has been described only
infrequently [1e7]. Low-grade central osteosarcoma is a rare
subtype of osteosarcoma, accounting for 1e2% of all osteosar-
comas [8,9]. Although its prognosis is excellent, with 90% overall
survival at 5 years [8], some cases of late metastasis have been
reported, and this may continue to impact survival even after 10
years [10].
Here we report a case of lung metastasis that occurred 17 years
after initial treatment of low-grade central osteosarcoma of the
distal femur. Radiologic evaluation revealed atypical pleural thick-
ening with calciﬁcation, spreading inward along with the periph-
eral pulmonary vasculature. Since the presentation and radiologic
manifestation of metastasis in this case were extremely unusual,
and demographic data are an essential part of diagnosis, the* Corresponding author. Department of Musculoskeletal Oncology, National
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3542 2511; fax: þ81 3 3542 3815.
E-mail address: akawai@ncc.go.jp (A. Kawai).
http://dx.doi.org/10.1016/j.jos.2015.08.002
0949-2658/© 2015 The Authors. Published by Elsevier B.V. on behalf of The Japanese O
This is an open access article under the CC BY-NC-ND license (http://creativecommons
Please cite this article in press as: Fujiwara T, et al., Atypical manifestation
osteosarcoma, Journal of Orthopaedic Science (2015), http://dx.doi.org/10present report adds novel information to existing knowledge, and
has implications for the follow-up and screening of patients with
low-grade central osteosarcoma.
The patient was informed that data concerning the case would
be submitted for publication, and she provided consent.2. Case report
A 37-year-old woman who had been followed up for 17 years
after treatment of osteosarcomawas found to have calciﬁed pleural
thickening in her left lung on radiographic examination. At the age
of 19 years, she had initially presented at another hospital with a
two-year history of occasional left knee pain. She had no relevant
medical history or family history. Plain radiographs had revealed
predominantly mixed, sclerotic, and lytic areas with well-deﬁned
margins within the left distal femur (Fig. 1A and B). Computed to-
mography (CT) demonstrated a densely sclerotic, eccentrically
located and slightly expansile soft tissue mass (Fig. 1C). Magnetic
resonance (MR) imaging demonstrated an intraosseous lesion with
intermediate to low signal intensity on both T1-weighted (Fig. 1D)
and T2-weighted images (Fig. 1E). 201Thallium and 99mTc bone
scintigraphy showed increased accumulation of the radioisotopes
in the lesion. The diagnosis obtained by open biopsy was conven-
tional osteosarcoma, and the patient received neoadjuvant
chemotherapy consisting of high-dose methotrexate, cisplatin, and
adriamycin. This was followed by wide resection of the tumor and
reconstruction using a modular-type prosthesis (Fig. 1F). After the
treatment, the patient was referred to our hospital for follow-up.
Histological review of the pathological slides revealed that the
majority of the tumor consisted of mildly atypical spindle cells
associated with long, well-formed bone trabeculae, often arranged
in parallel arrays (Fig. 2AeC). These ﬁndings were diagnostic of
low-grade osteosarcoma. Additionally, focal high-grade progres-
sion (dedifferentiation) characterized by higher cellularity, higher
nuclear atypia, or lace-like osteoid production was observed
(Fig. 2B).
The follow-up chest X-ray at our institution revealed calciﬁed
pleural thickening in the left thorax, which had not been presentrthopaedic Association.
.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Preoperative radiologic evaluation of the left distal femur. (A,B) Anteroposterior (A) and lateral (B) plain radiographs of the left distal femur displaying predominantly mixed,
sclerotic, and lytic areas with well-deﬁned margins. (C) Axial computed tomography (CT) view showing a densely sclerotic eccentrically located lesion anteromedial to a slightly
expansile soft tissue mass. (D,E) Axial magnetic resonance (MR) imaging view displaying an intraosseous lesion with intermediate signal intensity relative to skeletal muscle on
T1-weighted images (D) and homogeneous signal intensity on T2-weighted images (E). (F) Postoperative anteroposterior radiographs of the left distal femur.
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tion) computed tomography (CT) scan demonstrated pleural
thickening with deﬁnite calciﬁcation in the lower lobe of the left
lung, which had spread along the peripheral pulmonary vascula-
ture (Fig. 3C and D). There was no evidence of recurrence at the
primary site. 2-[ﬂuorine-18]-ﬂuoro-2-deoxy-D-glucose (FDG)
positron emission tomography (PET)-CT scan showed slightly
increased accumulation of FDG (SUV max: 2.4) in the pleural
lesion (Fig. 3E), but no abnormal uptake in any other parts of the
body. Since these ﬁndings suggested lung metastasis occurring a
long period after initial diagnosis, the patient underwent curative
partial resection of the left lower lobe. Macroscopically, the
resected specimen revealed circumscribed, tan-white masses with
calciﬁcation. The tumor was mainly located on the visceral pleura,
invading into the lung along the peripheral pulmonary vascula-
ture, as had been seen on the CT scan (Fig. 4A and B). Microscopic
evaluation revealed a well-formed bone matrix associatedPlease cite this article in press as: Fujiwara T, et al., Atypical manifestation
osteosarcoma, Journal of Orthopaedic Science (2015), http://dx.doi.org/10with relatively hypocellular proliferation of mildly atypical cells,
similar to the femoral primary lesion (Fig. 4C and D). No un-
equivocal high-grade morphology was present, although cellu-
larity and nuclear atypia were increased in focal areas. Therefore,
this was considered to be a rare case of low-grade central osteo-
sarcoma with focal dedifferentiation, which had metastasized to
the lung 17 years after initial diagnosis with atypical radiologic
features. The patient was discharged within one week after sur-
gery, and has since been well for one year, without any signs of
recurrence.
3. Discussion
Despite the use of combined modality therapy, 30e40% of os-
teosarcoma patients develop metastasis [11], the lung being the
most commonly affected site [4,12e14]. Almost one-third of pa-
tients with osteosarcoma suffer recurrence of the disease [15],of lung metastasis 17 years after initial diagnosis of low-grade central
.1016/j.jos.2015.08.002
Fig. 2. Histopathologyof the resected specimenof theprimary tumor. (A,C)Mildlyatypical spindlecells proliferate in fascicles associatedwith trabeculae of relativelymaturebonearranged
in parallel arrays. (B) Focal areas containing lace-like osteoid suggest high-grade progression (dedifferentiation). (hematoxylin and eosin stain, 20 (A,B) and 40 (C) magniﬁcation).
Fig. 3. Plain radiographs and CT images 17 years after initial diagnosis of the low-grade central osteosarcoma. (A,B) Chest plain radiograph (A) showing calciﬁed pleural thickening
in the left lower part of the left thorax (magniﬁed image; B). (C,D) Thin-section CT mediastinal window image (C) and lung window image (D) displaying calciﬁed pleural thickening
in the lower lobe of the left lung, which has spread along the peripheral pulmonary vasculature. (E) 2-[Fluorine-18]-ﬂuoro-2-deoxy-D-glucose (FDG) positron emission tomography
(PET)-CT scan showing slightly increased accumulation of FDG (SUV max: 2.4) in the left pleural lesion.
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Fig. 4. Histopathology of the resected specimen of lung metastasis. (A) Macroscopic view showing circumscribed, tan-white masses with calciﬁcation. (B) Microscopy image with
elastica van Gieson (EVG) staining, displaying the tumor located mainly on the visceral pleura, invading into the lung along the peripheral pulmonary vasculature, as was seen in the
CT scan. (C,D) Microscopy image with hematoxylin and eosin (HE) staining, showing relatively hypocellular spindle cell proliferation with mild nuclear atypia. Tumor cells show
mature bone formation. The ﬁndings are similar to those of the femoral primary lesion (hematoxylin and eosin stain, 20 (C) and 40 (D) magniﬁcation).
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after 5 disease-free years is uncommon [4]. Strauss et al. reviewed
the literature on late relapse of osteosarcoma, and reported that the
incidence rate of late relapse after 5 years was 0.6%e5.5%. The
Cooperative Osteosarcoma Study Group (COSS) reported the
longest metastasis-free interval of 14.3 years after treatment [1e7].
Recently, the longest metastasis-free time interval was reported by
Halldorsson et al. from Texas [15], which involved a 35-year-old
Caucasian American man who developed asymptomatic lung me-
tastases 21 years after being diagnosed and treated for osteosar-
coma of the left femur.
On the other hand, in a study of low-grade central osteosar-
coma, the incidence rate of late relapses was relatively high
(Table 1). The largest survivorship series has been published by
Choong et al. in 1996, based on an average follow-up period of
14.4 years [10]. In their series, 6 of 20 patients (30%) showed late
relapse beyond 5 years after treatment. Most of these relapses
were local recurrence, due to intralesional resection includingTable 1







Rizzoli Institute 10 Not stated 1 (10%)
Mayo Clinic 20 14.4 6 (30%)
MSKCC 14 5.3 0 (0%)
Royal Orthopaedic Hospital 18 7.3 1 (5.5%)
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metastases, 2 (40%) suffered distant metastasis 5 years after the
initial treatment [10]. Recently, Malhas et al. reported that one of
18 patients developed local recurrence and lung metastasis 8.5
years after wide resection of low-grade central osteosarcoma [16].
To date, the longest metastasis-free interval until formation of
lung metastasis after diagnosis of low-grade osteosarcoma was 8.5
years [17]. The period of 17 years until lung metastasis formation
in the present case of low-grade central osteosarcoma represents
the longest interval reported so far for this malignancy. The clin-
ical features of the present case suggest the importance of
continuous long-term follow-up of patients with low-grade cen-
tral osteosarcoma.
The radiologic appearance of lung metastasis is typically mul-
tiple round nodules of various sizes and diffuse thickening of the
interstitium [18e21]. In daily practice, however, lung metastases
with unusual radiologic features are frequently encountered,
making it difﬁcult to distinguish from other non-malignantarcoma.
patients relapsing
s (% rate)
Latest relapse (site) Author (year)
7 years (lung) Bertoni et al. (1992)
19.6 years (pelvic lymph node) Choong et al. (1996)
e Schwab et al. (2008)
8.5 years (lung) Malhas et al. (2012)
of lung metastasis 17 years after initial diagnosis of low-grade central
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various imaging features of lung metastases and demonstrated that
these included cavitation, calciﬁcation, hemorrhage around the
metastatic nodules, pneumothorax, an air-space pattern, tumor
embolism, endobronchial metastasis, a solitary mass, dilated ves-
sels within a mass, and sterilized metastasis [21]. Calciﬁcation of a
lung nodule usually suggests a benign nature, most commonly a
granuloma or hamartoma, but calciﬁcation or ossiﬁcation can also
occur in metastatic nodules from an osteosarcoma or chon-
drosarcoma [20,21]. In the present case, however, we identiﬁed
atypical pleural thickening with calciﬁcation, which had spread
along the peripheral pulmonary vasculature. Considering the pa-
tient's history of low-grade central osteosarcoma, we considered
the radiologic image to be an unusual manifestation of lung
metastasis. After curative partial resection of the lung metastasis,
the patient showed no evidence of disease at the last follow-up.
Mori et al. reported two cases of ‘kissing pleural metastasis’ [22]
in which lung metastases from osteosarcoma had migrated to the
parietal pleura due to contact. On the other hand, the lung
metastasis in the present case appeared to have spread inward from
the pleura, in the opposite direction. Examination of the patho-
logical specimen suggested that the tumor had metastasized to the
pleura and invaded into the lung tissue along the peripheral pul-
monary vasculature. To our knowledge, no previous report has
documented osteosarcoma lung metastasis exhibiting these
radiologic manifestations. Although the correlation of these ﬁnd-
ings with low-grade osteosarcoma metastasis has been unknown,
lung metastasis should be considered and appropriate treatment
planned if atypical pleural thickening with calciﬁcation invading
inward to the lung is encountered.
In summary, this report has documented the longest time in-
terval recorded to date for lung metastasis to appear after initial
treatment of low-grade central osteosarcoma. Despite an atypical
radiologic manifestation with calciﬁcation that spreads inward
from the pleura, lung metastasis should be included in the differ-
ential diagnosis and managed appropriately. This case shows that
careful long-term follow-up for more than 10 years is necessary for
patients with low-grade central osteosarcoma, and that early
diagnosis as well as early treatment for late relapse of this disease is
mandatory.Conﬂict of interest
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